Q4FY20 revenues grew 4.6% YoY to | 2301 crore. EBITDA margins expanded 163 bps YoY to 17.6% mainly due to lower other expenses on Ind-AS adjustment. Subsequent EBITDA grew 15.3% YoY to | 404 crore. However, PAT fell 37.4% YoY to | 131 crore. Delta vis-a-vis EBITDA was mainly due to higher interest & depreciation expenses due to Ind-AS 116....

Strong RoCE in GCC despite aggressive expansion Aster derives ~81% of revenues from GCC countries. In the last six years, the company has expanded its hospitals, clinics and pharmacy count by almost 2x. However, despite aggressive expansion, the RoCE has remained healthy (hospitals- 13% (established hospitals - 27%), clinics - 25% and pharmacies - 45%) due to 1) asset light model, 2) integrated business model, 3) faster occupancy owing to strong brand equity, 4) healthy ARPOB and 5) targeted strategy. We believe RoCE will improve further due to continuing...

Aster DM is one of the largest private healthcare service providers which operate in multiple GCC countries, and an emerging healthcare player in India.. The GCC operations (81% of sales) are headquartered in Dubai, United Arab Emirates and Indian operations (19% of sales) are headquartered in Kochi, Kerala. The company operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provides healthcare services to patients across economic segments in several GCC countries through their various brands Aster,...

Aster DM Healthcare Limited is one of the largest private healthcare service providers,whichoperateinmultipleGulfCooperationCouncil(GCC)statesandisan emerginghealthcareplayerinIndia.Thecompanyoperatesinmultiplesegmentsof thehealthcareindustry,includinghospitals,clinicsandretailpharmaciesandprovide healthcare services to patients across economic segments in several GCC states. Incorporated in 2008 in a reorganisation to facilitate the growth of operations,...

IPO NOTE

Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects: Repayment and/or pre-payment of debt;...

Aster DM Healthcare Ltd. (Aster) is one of the largest private healthcare service providers, having operations in multiple GCC (Cooperation Council for the Arab States of the Gulf) states based on numbers of hospitals and clinics. The issue is a combination of fresh and OFS. The company will not receive any proceeds from the OFS. Net proceeds from the fresh issue would be around Rs. 6,750mn. Of the net proceeds, around Rs. 5,641.6mn, would be utilized to prepay and/or repayment of the...

HDFC sec IPO Note - Aster DM Healthcare Limited Issue Open: Feb 12 - Feb 15, 2018, Price Band: Rs. 180 - 190, Issue Size: 51,586,146 Equity Shares (Including Fresh issue of *38,157,895 eq, sh + Offer for sale of 13,428,251 eq sh), Offer Size: Rs.928.55cr - 980.13cr

The Offer comprises of the Fresh Issue and the Offer for Sale. Object of the fresh issue are as follows: 1. Repayment and/or pre-payment of debt...

Aster DM Healthcare Ltd (ADHL) is one of the largest private healthcare service providers which operates in multiple GCC states and is an emerging healthcare player in India. ADHL operates in all of the GCC states (UAE, Oman, Saudi Arabia, Qatar, Kuwait, Bahrain and Jordan), India and the Philippines. The company operates in multiple segm..